NSEGeneral Updates20 Jun 2026 · 20 Jun 2026, 07:07 pm
General Updates
MEDPLUS · MEDPLUS
✦ AI Summary
MedPlus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License. This order pertains to one of its stores located in the state of Maharashtra. The suspension means the affected store cannot operate, representing an operational disruption for the subsidiary. This update was provided to the exchanges under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
General Updates
Attachments (1)
📄pdf
Download →
MEDPLUS_20062026190700_Intimation.pdf
View document text
MedPlus Health Services Limited
June 20, 2026
The Listing Department The Listing Department
BSE Limited N ational Stock Exchange of India Limited
Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Fort, Plot No. C/1, G Block,
Mumbai – 400001 Bandra - Kurla Complex
BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051
NSE Symbol: MEDPLUS
Dear Sir/Madam,
Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has
received one suspension order for a Drug License of a store situated in the state of Maharashtra:
Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows:
Name(s) of the Authority Nature and details Date of receipt Details of the Impact on
of the action(s) of direction or violation(s)/ financial
taken, initiated or order, including contravention(s) operation or
order(s) passed any interim or committed or other activities
interim orders, alleged to be of the listed
or any other committed entity,
communication quantifiable in
from the monetary terms
authority to the extent
possible
Asst. Commissioner & Suspension of Drug Order received Under Rule 65 of Potential
Licensing authority, Food License for 10 days on 20.06.2026 Drugs and Revenue Loss of
& Drug Administrations, of store situated at Cosmetics Act, 1940 Rs 2.68 lacs.
MH, PUNE Mr. Chowk Saswad and Drugs and
R.V.PONGALE . Pune Cosmetics Rules,
1945
The same will be available on the website of the Company at www.medplusindia.com and also on the websites
of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com
respectively. Kindly take the same on records.
For MedPlus Health Services Limited
Gangadi Madhukar Reddy
Managing Director and Chief Executive Officer
DIN: 00098097
040-6724 672
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com